Skip to main content

Tinnitus, Hearing Loss, Cochlear Implant Users

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Cell Therapy
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cochlear
CochlearAustralia - Macquarie Park
1 program
CART sound therapyN/ACell Therapy1 trial
Active Trials
NCT03026829Terminated32Est. Jan 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CochlearCART sound therapy

Clinical Trials (1)

Total enrollment: 32 patients across 1 trials

NCT03026829CochlearCART sound therapy

Sound Therapy for Tinnitus Relief in Cochlear Implant Users

Start: Oct 2017Est. completion: Jan 201932 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.